We are so grateful for the community and for the outpouring of kindness and generosity toward Cedars-Sinai during this time. We are truly touched by this extraordinary commitment as the world continues to face the COVID-19 (coronavirus) pandemic—from offering kind words that fill our hearts to donating money and supplies that keep our front-line staff prepared, rested, fed and, most importantly, safe. Your thoughtful gestures mean so much to everyone here.
As we continue to treat and care for patients across the community, we wanted to share more about new initiatives in development across the Cedars-Sinai enterprise. Right now, we are preparing for projected increases in patients with COVID-19 seeking treatment at Cedars-Sinai. Over the last few weeks, we have been preparing for this surge by doing the following:
- Ensuring that our front-line clinical staff have the supplies and equipment needed to protect themselves and to care for patients. Our leadership team is in ongoing contact with a variety of suppliers worldwide to sustain our needs to support our staff and our patients over an extended period.
- Strengthening our care teams and training nurses who specialize in other areas to have the skills needed to also work in our intensive care unit. Every day, nurses at Cedars-Sinai provide the best in care to patients and their families, and as we prepare for this projected surge, we want to be sure that our nurses have the expertise to treat patients in every scenario. Cedars-Sinai is built on this tradition of teamwork—especially in times of great need.
- Establishing a COVID-19 Research Task Force to centralize all COVID-19 research-related activities at Cedars-Sinai. This group is coordinating all ongoing, planned and already initiated COVID-19 research efforts; identifying collaborative opportunities both within Cedars-Sinai and at institutions around the world; and sharing all that is learned about COVID-19 with our investigators.
You play a key role in these important developments—your gifts make these efforts possible. If you would like to support our COVID-19 response or would like to learn more about our care and research efforts, please visit cedars-sinai.org. We can only do this work with your partnership.
Thank you for all that you do for Cedars-Sinai and the patients and families who come to us for health and hope.
About Thomas Priselac
An advocate for improving quality and access in healthcare, Thomas M. Priselac has developed strategic and operational innovations to foster high-quality, safe and efficient care for patients. Under his leadership, Cedars-Sinai has earned an international reputation for quality care, community service, research and education while evolving from a community hospital to a major health system that continues to expand to better serve patients. Priselac, who holds the Warschaw Law Chair in Healthcare Leadership at Cedars-Sinai, first joined Cedars-Sinai in 1979, and has been president and CEO since 1994.
Before being appointed to his current role, he was executive vice president of Cedars-Sinai from 1988 to 1993. Earlier in his career, he was on the executive staff of Montefiore Hospital in Pittsburgh.
An authority on healthcare delivery and policy, Priselac is a past chair of the American Hospital Association Board of Trustees and a past chair of the Association of American Medical Colleges. When he was chair of the American Hospital Association in 2009, he had an instrumental role in the development of Affordable Care Act. He also formerly chaired the California Hospital Association and the Hospital Association of Southern California.
He is a member of the Board of Councilors of the Charles R. Drew University of Medicine and Science, Civic Alliance, the Los Angeles Coalition for the Economy and Jobs, the Los Angeles County Economic Development Corporation and the Los Angeles Area Chamber of Commerce. Priselac has received numerous awards for his leadership in healthcare and his commitment to improving the health of the underserved, including the American Hospital Association’s Distinguished Service Award, B’nai Brith International’s National Healthcare Award, the Special Needs Network’s Distinguished Community Champion Corporate Leadership Award and the Charles R. Drew University Board of Trustees Medal of Honor.
Priselac writes and speaks on a variety of policy issues related to the delivery and financing of healthcare, healthcare quality and safety, and the adoption and implementation of information technology. He is an adjunct professor at the UCLA Fielding School of Public Health, where he teaches principles of organizational leadership.
Priselac earned a bachelor’s degree in biology from Washington and Jefferson College in Pennsylvania, and a master’s degree in public health, health services administration and planning from the University of Pittsburgh.